Jane Street’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,900
Closed -$68.8K 10110
2024
Q3
$68.8K Sell
20,900
-600
-3% -$2.34K ﹤0.01% 9105
2024
Q2
$91.4K Sell
21,500
-18,300
-46% -$178K ﹤0.01% 8762
2024
Q1
$586K Buy
+39,800
New +$602K ﹤0.01% 6375
2022
Q1
Sell
-28,800
Closed -$462K 10743
2021
Q4
$462K Buy
28,800
+11,800
+69% +$222K ﹤0.01% 7422
2021
Q3
$356K Sell
17,000
-9,300
-35% -$224K ﹤0.01% 7862
2021
Q2
$706K Buy
26,300
+500
+2% +$14.6K ﹤0.01% 6574
2021
Q1
$822K Buy
25,800
+6,500
+34% +$158K ﹤0.01% 5840
2020
Q4
$441K Sell
19,300
-7,000
-27% -$161K ﹤0.01% 5920
2020
Q3
$662K Buy
26,300
+15,200
+137% +$415K ﹤0.01% 4743
2020
Q2
$310K Buy
+11,100
New +$193K ﹤0.01% 5786

Other funds holding MGNX

Jane Street's MGNX Position: Q1 2026 in Review

Jane Street reduced its MacroGenics (MGNX) stake by 52% in Q1 2026, selling an estimated $1.38M and leaving 608,509 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #5341.

Jane Street first reported a position in MGNX in Q2 2014 and has held it in 26 quarters since. The position peaked at $5.57M in Q1 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Jane Street held 608,509 shares of MacroGenics worth $1.76M as of Q1 2026.
  • Jane Street sold 646,414 MacroGenics shares in Q1 2026, an estimated $1.38M.
  • MacroGenics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5341 holding.
  • Jane Street first reported a position in MacroGenics in Q2 2014 and has held it in 26 quarters since.
  • Jane Street's MacroGenics position peaked at $5.57M in Q1 2024.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.